Pages that link to "Q36836254"

The following pages link to The prognostic value of PET and PET/CT in cervical cancer (Q36836254):

Displaying 18 items.

• Postoperation of cervical cancer with intestine metastasis: a case report and literature review (Q28075510) (← links)
• Variable uterine uptake of FDG in adenomyosis during concurrent chemoradiation therapy for cervical cancer (Q36195997) (← links)
• Intracardiac metastasis from known cervical cancer: a case report and literature review (Q36885153) (← links)
• Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond (Q37036792) (← links)
• Gynecologic tumors: how to communicate imaging results to the surgeon (Q37489792) (← links)
• Chemoradiotherapy for cervical cancer in 2010 (Q37806149) (← links)
• PET/CT in Gynecologic Cancer: Present Applications and Future Prospects—A Clinician’s Perspective (Q37854986) (← links)
• Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps (Q38413433) (← links)
• Hypoxia in cervical cancer: from biology to imaging (Q38643119) (← links)
• Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study (Q39290627) (← links)
• Glucose‐regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer (Q39473996) (← links)
• Snake-like hypermobile masses in three chambers of the heart: very unusual metastasis of squamous cell carcinoma (Q42185585) (← links)
• Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging (Q42587608) (← links)
• Pretreatment metabolic tumour volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy. (Q48323125) (← links)
• To operate or to radiate: the added value of the maximal standardized uptake value in PET-FDG in cervical cancer patients. (Q53114686) (← links)
• Therapeutic value of surgical paraaortic staging in locally advanced cervical cancer: a multicenter cohort analysis from the FRANCOGYN study group (Q59809005) (← links)
• Cardiac metastasis in cervical cancer (Q92583711) (← links)
• Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma (Q92994032) (← links)